speaker-icon

Latest Posts

Partex-Lupin-press-release-illustration

23

Apr 24

Partex Partners with Lupin to Revolutionize Drug Discovery through AI-Driven Asset Search and Evaluation

Frankfurt, Germany, 23 April 2024 – Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled to...
Read More
Partex-NV-announces-collaboration-with-Althea-DRF-Lifesciences

28

Mar 24

Partex NV announces collaboration with Althea DRF Lifesciences to provide comprehensive end-to-end services to accelerate drug discovery and development

Frankfurt, Germany; 28 March 2024 – Partex Group, a pioneer in AI-driven drug discovery, announces a collaboration with Althea DRF...
Read More

Innoplexus wins Horizon Interactive Gold Award for Curia App

Read More

Author name: Gunjan Bhardwaj

Gunjan Bhardwaj is the founder and CEO of Innoplexus, a leader in AI and analytics as a service for life science industries. With a background at Boston Consulting Group and Ernst & Young, he bridges the worlds of AI, consulting, and life science to drive innovation.

ontosight-discover

An AI-based solution to extract real-time insights from the ever-growing scientific data

The pharmaceutical industry saves millions of lives every year, and in doing so, it needs to constantly improve existing therapies, find new ones, and take advantage of the large volume of growing scientific and medical data. It is often a herculean task to access all relevant data in real time, let alone make connections in …

An AI-based solution to extract real-time insights from the ever-growing scientific data Read More »

Inside-the-cockpit-by_gunjan-bhardwaj

You Can’t Find the Needle If You Don’t Know It Exists

This blog is adapted from my book titled “Inside the Cockpit: Navigating the Complexity of Drug Development with AI and Blockchain”. Full copies are available here.  In December 2014, a twenty-nine-year-old investor named Vivek Ramaswamy bought a patent from GlaxoSmithKline (GSK) for $5 million. The patent covered an Alzheimer’s drug candidate that had failed GSK’s …

You Can’t Find the Needle If You Don’t Know It Exists Read More »

artificial-intelligence

How AI and Big Data is transforming the future of healthcare

Dr. Gunjan Bhardwaj with Shanna Landolt for an exclusive podcast on how AI and Big Data is transforming the future of healthcare. http://traffic.libsyn.com/force-cdn/highwinds/shannalandolt/Dr._Gunjan_Bhardwaj.mp4 Gunjan Bhardwaj is the Founder and CEO of the Innoplexus group. He was earlier with the Boston Consulting Group and before that the leader of the global business performance think-tank of Ernst …

How AI and Big Data is transforming the future of healthcare Read More »

aI-blockchain

How AI And Blockchain can revolutionize pharmaceutical trials

It’s widely known by the pharmaceutical community that nearly nine out of ten drug candidates fail to win FDA approval, resulting in enormous drug development expenses every year. Less commonly understood is the underlying cause of these high failure rates, and what the pharmaceutical industry can do to overcome this challenge. Currently, in an effort …

How AI And Blockchain can revolutionize pharmaceutical trials Read More »

open-data

Is Open Data the silver bullet for better drugs?

Open data sharing within the pharmaceutical industry is crucial for opening the floodgates of innovation. Successful innovation depends on having a rich supply of high-quality data because, without the right kind and quantity of data, there wouldn’t be a foundation for the research required to innovate. The best way to achieve this critical mass of …

Is Open Data the silver bullet for better drugs? Read More »

STUDY_US-Consumer-Perceptions-of-Pharmaceutical-Companies-01

Our consumer perceptions of Pharma survey: Top ten findings

Download PPT Despite the millions of lives that are saved by pharmaceutical drugs each year, the pharmaceutical industry struggles against an enduring bad reputation. It’s not difficult to find statistics attesting to the frustration that many consumers feel about rising drug prices, corruption, and other real challenges that pharmaceutical companies face. But despite the negative …

Our consumer perceptions of Pharma survey: Top ten findings Read More »